Time-course of kynurenic acid concentration in mouse serum following the administration of a novel kynurenic acid analog

Journal of Pharmaceutical and Biomedical Analysis

Volumn 55, Issue 3, 2011, Pages 540-543

  Zádori, Dénes ^a   Ilisz, István ^b   Klivényi, Péter ^a   Szatmári, István ^c   Fülöp, Ferenc ^c   Toldi, József ^b   Vécsei, László ^a   Péter, Antal ^b  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

^c UNIVERSITY OF SZEGED   (Hungary)

Author keywords

High performance liquid chromatography; Kynurenic acid; Kynurenic acid analog; Mass spectrometry; Pharmacokinetic study

Indexed keywords

KYNURENIC ACID;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ARTICLE; FLUORESCENCE SPECTROSCOPY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOUSE; NERVOUS SYSTEM; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG EVALUATION, PRECLINICAL; FEMALE; INJECTIONS, INTRAPERITONEAL; KYNURENIC ACID; LIMIT OF DETECTION; MALE; MICE; MICE, INBRED C57BL; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

EID: 79953225482     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2011.02.014     Document Type: Article

References (31)

1. Kynurenines in the Brain 2005, Nova Science Publishers, Inc., New York. L. Vecsei (Ed.).
2. Nemeth H., Toldi J., Vecsei L. Role of kynurenines in the central and peripheral nervous systems. Curr. Neurovasc. Res. 2005, 2:249-260.
3. Zadori D., Klivenyi P., Vamos E., Fulop F., Toldi J., Vecsei L. Kynurenines in chronic neurodegenerative disorders: future therapeutic strategies. J. Neural Transm. 2009, 116:1403-1409.
4. Stone T.W., Darlington L.G. Endogenous kynurenines as targets for drug discovery and development. Nat. Rev. Drug. Discov. 2002, 1:609-620.
5. Fukui S., Schwarcz R., Rapoport S.I., Takada Y., Smith Q.R. Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism. J. Neurochem. 1991, 56:2007-2017.
6. Bahn A., Ljubojevic M., Lorenz H., Schultz C., Ghebremedhin E., Ugele B., Sabolic I., Burckhardt G., Hagos Y. Murine renal organic anion transporters mOAT1 and mOAT3 facilitate the transport of neuroactive tryptophan metabolites. Am. J. Physiol. Cell. Physiol. 2005, 289:C1075-1084.
7. Schwarcz R. The kynurenine pathway of tryptophan degradation as a drug target. Curr. Opin. Pharmacol. 2004, 4:12-17.
8. Stone T.W. Development and therapeutic potential of kynurenic acid and kynurenine derivatives for neuroprotection. Trends Pharmacol. Sci. 2000, 21:149-154.
9. Fulop F., Szatmari I., Vamos E., Zadori D., Toldi J., Vecsei L. Syntheses, transformations and pharmaceutical applications of kynurenic acid derivatives. Curr. Med. Chem. 2009, 16:4828-4842.
10. Marosi M., Nagy D., Farkas T., Kis Z., Rozsa E., Robotka H., Fulop F., Vecsei L., Toldi J. A novel kynurenic acid analogue: a comparison with kynurenic acid. An in vitro electrophysiological study. J. Neural Transm. 2010, 117:183-188.
11. Vamos E., Pardutz A., Varga H., Bohar Z., Tajti J., Fulop F., Toldi J., Vecsei L. l-Kynurenine combined with probenecid and the novel synthetic kynurenic acid derivative attenuate nitroglycerin-induced nNOS in the rat caudal trigeminal nucleus. Neuropharmacology 2009, 57:425-429.
12. Vamos E., Fejes A., Koch J., Tajti J., Fulop F., Toldi J., Pardutz A., Vecsei L. Kynurenate derivative attenuates the nitroglycerin-induced CamKIIalpha and CGRP expression changes. Headache 2010, 50:834-843.
13. D. Zadori, G. Nyiri, A. Szonyi, I. Szatmari, F. Fulop, J. Toldi, T.F. Freund, L. Vecsei, P. Klivenyi, Neuroprotective effects of a novel kynurenic acid analogue in a transgenic mouse model of Huntington's disease, J. Neural Transm., doi:10.1007/s00702-010-0573-6.
14. Zhang X., He Y., Ding M. Simultaneous determination of tryptophan and kynurenine in plasma samples of children patients with Kawasaki disease by high-performance liquid chromatography with programmed wavelength ultraviolet detection. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2009, 877:1678-1682.
15. Ma L., Xu B., Wang W., Deng W., Ding M. Analysis of tryptophan catabolism in HBV patients by HPLC with programmed wavelength ultraviolet detection. Clin. Chim. Acta 2009, 405:94-96.
16. Baran H., Gramer M., Honack D., Loscher W. Systemic administration of kainate induces marked increases of endogenous kynurenic acid in various brain regions and plasma of rats. Eur. J. Pharmacol. 1995, 286:167-175.
17. Mitsuhashi S., Fukushima T., Kawai J., Tomiya M., Santa T., Imai K., Toyo'oka T. Improved method for the determination of kynurenic acid in rat plasma by column-switching HPLC with post-column fluorescence detection. Anal. Chim. Acta 2006, 562:36-43.
18. Mitsuhashi S., Fukushima T., Arai K., Tomiya M., Santa T., Imai K., Toyo'oka T. Development of a column-switching high-performance liquid chromatography for kynurenine enantiomers and its application to a pharmacokinetic study in rat plasma. Anal. Chim. Acta 2007, 587:60-66.
19. Fukushima T., Mitsuhashi S., Tomiya M., Iyo M., Hashimoto K., Toyo'oka T. Determination of kynurenic acid in human serum and its correlation with the concentration of certain amino acids. Clin. Chim. Acta 2007, 377:174-178.
20. Xiao L.D., Luo X.B., Pi L.G., Tang A.G., Xiao L.D. Simultaneous determination of kynurenine and kynurenic acid concentrations in human serum by HPLC with dual wavelengths fluorescence detection. Clin. Chim. Acta 2008, 395:178-180.
21. Pi L.G., Tang A.G., Mo X.M., Luo X.B., Ao X. More rapid and sensitive method for simultaneous determination of tryptophan and kynurenic acid by HPLC. Clin. Biochem. 2009, 42:420-425.
22. Fukushima T., Sone Y., Mitsuhashi S., Tomiya M., Toyo'oka T. Alteration of kynurenic acid concentration in rat plasma following optically pure kynurenine administration: a comparative study between enantiomers. Chirality 2009, 21:468-472.
23. Vecsei L., Miller J., MacGarvey U., Beal M.F. Effects of kynurenine and probenecid on plasma and brain tissue concentrations of kynurenic acid. Neurodegeneration 1992, 1:17-26.
24. Amirkhani A., Heldin E., Markides K.E., Bergquist J. Quantitation of tryptophan, kynurenine and kynurenic acid in human plasma by capillary liquid chromatography-electrospray ionization tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2002, 780:381-387.
25. Amirkhani A., Rajda C., Arvidsson B., Bencsik K., Boda K., Seres E., Markides K.E., Vecsei L., Bergquist J. Interferon-beta affects the tryptophan metabolism in multiple sclerosis patients. Eur. J. Neurol. 2005, 12:625-631.
26. Yamada K., Miyazaki T., Shibata T., Hara N., Tsuchiya M. Simultaneous measurement of tryptophan and related compounds by liquid chromatography/electrospray ionization tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2008, 867:57-61.
27. de Jong W.H.A., Smit R., Bakker S.J.L., de Vries E.G.E., Kema I.P. Plasma tryptophan, kynurenine and 3-hydroxykynurenine measurement using automated on-line solid-phase extraction HPLC-tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2009, 877:603-609.
28. Arvidsson B., Johannesson N., Citterio A., Righetti P.G., Bergquist J. High throughput analysis of tryptophan metabolites in a complex matrix using capillary electrophoresis coupled to time-of-flight mass spectrometry. J. Chromatogr. A 2007, 1159:154-158.
29. Zhang Y., Huo M., Zhou J., Xie S. PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Comput. Methods Programs Biomed. 2010, 99:306-314.
30. Ishii K., Ogaya T., Song Z., Iizuka H., Fukushima T. Changes in the plasma concentrations of d-kynurenine and kynurenic acid in rats after intraperitoneal administration of tryptophan enantiomers. Chirality 2010, 22:901-906.
31. ICH harmonised tripartite guideline Q2(R1) Validation of analytical procedures: text and methodology Q2(R1). Proceedings of the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use 2005.